Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

H1N1 Vaccine Update: Big Sales To Come In Fourth Quarter, Mfrs. Say

Executive Summary

The pandemic influenza situation is leaving the biopharmaceutical industry in a healthy state - with early reports of vaccine sales having notable impact on manufacturers' bottom lines, revitalization for waning antiviral products and accelerated pathways for novel products

You may also be interested in...



Possibility Of A Pandemic Helped GSK’s Q-Pan H5N1 Flu Vaccine Get Panel Support

FDA’s Vaccines and Related Biological Products Advisory Committee said in twin 14-0 votes that immunogenicity and safety data are sufficient to support approval.

FDA Scientists Take Recombinant Step Toward Faster Development Of Flu Vaccines

Scientists at FDA have taken a step toward speeding the approval of influenza vaccines: They have demonstrated a faster way to produce the reagent used to evaluate a vaccine's potency.

FDA Scientists Take Recombinant Step Toward Faster Development Of Flu Vaccines

Scientists at FDA have taken a step toward speeding the approval of influenza vaccines: They have demonstrated a faster way to produce the reagent used to evaluate a vaccine's potency.

Related Content

Topics

UsernamePublicRestriction

Register

PS051631

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel